RONDOMYCIN Drug Patent Profile
✉ Email this page to a colleague
When do Rondomycin patents expire, and when can generic versions of Rondomycin launch?
Rondomycin is a drug marketed by Medpointe Pharm Hlc and is included in one NDA.
The generic ingredient in RONDOMYCIN is methacycline hydrochloride. There are six drug master file entries for this compound. Additional details are available on the methacycline hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RONDOMYCIN?
- What are the global sales for RONDOMYCIN?
- What is Average Wholesale Price for RONDOMYCIN?
Summary for RONDOMYCIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 47 |
| Patent Applications: | 4,153 |
| DailyMed Link: | RONDOMYCIN at DailyMed |
US Patents and Regulatory Information for RONDOMYCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medpointe Pharm Hlc | RONDOMYCIN | methacycline hydrochloride | CAPSULE;ORAL | 060641-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Medpointe Pharm Hlc | RONDOMYCIN | methacycline hydrochloride | CAPSULE;ORAL | 060641-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Medpointe Pharm Hlc | RONDOMYCIN | methacycline hydrochloride | SYRUP;ORAL | 060641-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
